Herbal drugs: standards and regulation.

The use of herbal drugs for the prevention and treatment of various health ailments has been in practice from time immemorial. Generally it is believed that the risk associated with herbal drugs is very less, but reports on serious reactions are indicating to the need for development of effective marker systems for isolation and identification of the individual components. Standards for herbal drugs are being developed worldwide but as yet there is no common consensus as to how these should be adopted. Standardization, stability and quality control for herbal drugs are feasible, but difficult to accomplish. Further, the regulation of these drugs is not uniform across countries. There are variations in the methods used across medicine systems and countries in achieving stability and quality control. The present study attempts to identify the evolution of technical standards in manufacturing and the regulatory guideline development for commercialization of herbal drugs.

[1]  K. G. Ramawat,et al.  Bioactive molecules and medicinal plants , 2008 .

[2]  P. Dargan,et al.  Heavy metal poisoning from Ayurvedic traditional medicines: an emerging problem? , 2008 .

[3]  M. Gershwin,et al.  Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life sciences.

[4]  S. Trueman,et al.  Clonality and sexual reproductive failure in remnant populations of Santalum lanceolatum (Santalaceae) , 2000 .

[5]  Y. Lam,et al.  Identification of a novel vardenafil analogue in herbal product. , 2008, Journal of pharmaceutical and biomedical analysis.

[6]  Kevin Yi-Lwern Yap,et al.  The reliability of traditional authentication – a case of ginseng misfit , 2008 .

[7]  Jian Xue,et al.  Residues of 18 organochlorine pesticides in 30 traditional Chinese medicines. , 2008, Chemosphere.

[8]  E. Ernst.  Toxic heavy metals and undeclared drugs in Asian herbal medicines. , 2002, Trends in pharmacological sciences.

[9]  P. Kakkar,et al.  Toxic metals and organochlorine pesticides residue in single herbal drugs used in important ayurvedic formulation – ‘Dashmoola’ , 2008, Environmental monitoring and assessment.

[10]  P. R. Petrovick,et al.  New rules for phytopharmaceutical drug registration in Brazil. , 1999, Journal of ethnopharmacology.

[11]  Roger B. Davis,et al.  Heavy metal content of ayurvedic herbal medicine products. , 2004, JAMA.

[12]  Roger B. Davis,et al.  Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. , 2008, JAMA.

[13]  Don Woong Choi,et al.  Regulation and quality control of herbal drugs in Korea. , 2002, Toxicology.

[14]  S. M. Rates,et al.  Plants as source of drugs. , 2001, Toxicon : official journal of the International Society on Toxinology.

[15]  E. Ong.  Extraction methods and chemical standardization of botanicals and herbal preparations. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  H. Ang,.  Lead contamination in Eugenia dyeriana herbal preparations from different commercial sources in Malaysia. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  Shaily Goyal,et al.  The Indian Herbal Drugs Scenario in Global Perspectives , 2008 .

[18]  L. Cuzzolin,et al.  Safety implications regarding use of phytomedicines , 2005, European Journal of Clinical Pharmacology.

[19]  Jules Janick,et al.  Perspectives on new crops and new uses , 1999 .

[20]  G. Mazzanti,et al.  Purity control of some Chinese crude herbal drugs marketed in Italy. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  Shen-Kuan Yee,et al.  Regulatory control of Chinese Proprietary Medicines in Singapore. , 2005, Health policy.

[22]  Terezinha de Jesus Andreoli Pinto,et al.  Occurrence of toxigenic fungi in herbal drugs , 2006 .

[23]  M Elvin-Lewis,et al.  Should we be concerned about herbal remedies. , 2001, Journal of ethnopharmacology.

[24]  Bhushan Patwardhan,et al.  Molecular markers in herbal drug technology , 2004 .

[25]  D. Schuppan,et al.  Herbal medicine in the treatment of liver diseases. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[26]  M. Iwu,et al.  New Antimicrobials of Plant Origin , 1999 .

[27]  Yi-Zeng Liang,et al.  Quality control of herbal medicines. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  Hongxi Xu,et al.  Chemical markers for the quality control of herbal medicines: an overview , 2008, Chinese medicine.

[29]  P. Mukherjee,et al.  Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. , 2006, Journal of ethnopharmacology.

[30]  P. Saxena,et al.  Approaches to Quality Plant Based Medicine: Significance of Chemical Profiling , 2007 .

[31]  L. Bielory,et al.  Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. , 2009, The Journal of allergy and clinical immunology.

[32]  U. Solimene,et al.  WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues , 2007 .

[33]  A. Rawat,et al.  Heavy Metal Accumulation in Some Herbal Drugs , 2001 .

[34]  K. Stewart.  The African cherry (Prunus africana): can lessons be learned from an over-exploited medicinal tree? , 2003, Journal of ethnopharmacology.

[35]  Kelvin Chan,et al.  Some aspects of toxic contaminants in herbal medicines. , 2003, Chemosphere.

[36]  R. Verpoorte,et al.  Applications of plant metabolic engineering , 2007 .